CCX-777
1226686-36-7
|
(R)-CCX-777
1257861-18-9
|
(S)-CCX-777
1257861-17-8
|
CCR1 antagonist 1
1010073-75-2
|
(Z)-3-hepten-1-yl acetate
1576-78-9
|
2-(4'-fluorobiphenyl-4-yl)ethanamine hydrochloride
1189922-22-2
|
1-azoniabicyclo[3.3.1]nonan-2-yl 2,2-diphenylacetate,chloride
73855-72-8
|
3-[(2E)-2-[[3-(2-carboxyethyl)-5-[[(2S,3R,4R)-3-ethyl-4-methyl-5-oxopyrrolidin-2-yl]methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[[(2S,3R,4R)-4-ethyl-3-methyl-5-oxopyrrolidin-2-yl]methyl]-4-methylpyrrol-3-yl]propanoic acid;hydrochloride
5370-34-3
|
1-Palmitoyl-2-Pyropheophorbide a-sn-glycero-3-PC
1287795-07-6
|
10(R)-hydroxy-9(S)-Hexahydrocannabinol
60948-21-2
|
(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-(4-fluorobenzoyl)oxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
1454575-38-2
|
Dermaseptin TFA
646451-06-1
|
N6-[(6-Aminohexyl)carbamoylmethyl]-ADP
100826-95-7
|
8(S)-hydroxy-9(R)-Hexahydrocannabinol
74509-39-0
|
8-Bromo-2'-deoxyadenosine-5'-O-triphosphate (sodium salt)
1188369-62-1
|
2-(4-amino-2-oxopyrimidin-1-yl)-N-[2,3-bis[(E)-octadec-9-enoxy]propyl]acetamide
2226561-66-4
|
MTDB-Alkyne
2923694-73-7
|
